Clinical Trials on Chromosome 5q Deletion

Total 1598 results

Radboud University Medical Center

Active, not recruiting

Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome

Turner Syndrome | Premature Ovarian Failure | Fertility Preservation | Live Birth | Ovarian Tissue Cryopreservation

Netherlands
Nemours Children's Clinic
Eli Lilly and Company

Completed

Estrogen Treatment (Oral vs. Patches) in Turner Syndrome

Hypogonadism | Turner Syndrome | Premature Ovarian Failure

United States
Merck KGaA, Darmstadt, Germany

Completed

Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector

Growth Hormone Deficiency | Chronic Renal Failure | Turner Syndrome | Small for Gestational Age
Craig Erickson
Healx Limited

Recruiting

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

Fragile X Syndrome

United States
Elizabeth Berry-Kravis

Completed

Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Syndrome

Fragile X Syndrome

United States
Novartis Pharmaceuticals

Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

Fragile X Syndrome

United States, Spain
Rowan University
University of Pennsylvania; FRAXA Research Foundation

Unknown

Metformin in Patients With Fragile X

Fragile X Syndrome

United States
Hoffmann-La Roche

Completed

A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome

Fragile X Syndrome

United States
Hoffmann-La Roche

Completed

A Study of RO4917523 in Patients With Fragile X Syndrome

Fragile X Syndrome

France, Spain, United States, Peru, Canada, United Kingdom, Chile, Argentina, Mexico, Sweden
Yolanda de Diego Otero

Completed

Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome (SXF-TRA152)

Fragile X Syndrome

Spain
Seaside Therapeutics, Inc.

Completed

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

Fragile X Syndrome

United States
Seaside Therapeutics, Inc.

Terminated

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

Fragile X Syndrome

United States
Niramai Health Analytix Private Limited
Max Healthcare Insititute Limited

Completed

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Breast Cancer | Early Detection of Cancer

India
Delphinus Medical Technologies, Inc.
University of Chicago; Boston Biomedical Associates; Reed Technical Associates...

Completed

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS2)

Breast Cancer Detection | Dense Breast Parenchyma | Benign Breast Findings | Normal Breast Screening | Abnormal Breast Screening

United States
Changhai Hospital

Unknown

Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy

Adenoma Detection Rate | Bowel Preparation Scale | the Amount of Air Bubble

China
Ganin Fertility Center

Unknown

PGTai Results for Embryos Cultured in Sequential Versus Single Step Media

Infertility | Mosaicism | Aneuploidy Rate

Egypt
Université de Sherbrooke
Canadian Institutes of Health Research (CIHR); Centre de recherche du Centre... and other collaborators

Not yet recruiting

Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome (CANAX)

Fragile X Syndrome
Institute of Hematology & Blood Diseases Hospital

Recruiting

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

China
Tetra Discovery Partners

Recruiting

A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Fragile X Syndrome

United States
Children's Hospital of Fudan University

Recruiting

Metformin in Children With Fragile X Syndrome

Fragile X Syndrome | Metformin

China
Tetra Discovery Partners

Enrolling by invitation

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Fragile X Syndrome

United States
Healx Limited

Withdrawn

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40 (IMPACT-FXS)

Fragile X Syndrome

United States, Australia
Children's Hospital Medical Center, Cincinnati

Completed

An Initial Study of AZD7325 in Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Université de Sherbrooke
FRAXA Research Foundation

Completed

Metformin in Children and Adults With Fragile X Syndrome

Fragile X Syndrome

Canada
Novartis

Completed

Efficacy, Safety and Tolerability of AFQ056 in Fragile X Patients

Fragile X Syndrome

France, Italy, Switzerland
Neuren Pharmaceuticals Limited

Completed

A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome

Fragile X Syndrome

United States
Randi J. Hagerman, MD

Completed

Trial of Sertraline to Treat Children With Fragile X Syndrome

Fragile X Syndrome

United States
Indiana University
Indiana Clinical and Translational Sciences Institute

Completed

Riluzole in Fragile X Syndrome

Fragile X Syndrome

United States
Indiana University School of Medicine

Completed

A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

Fragile X Syndrome

United States
Hoffmann-La Roche

Completed

A Study With RO4917523 in Patients With Fragile X Syndrome

Fragile X Syndrome

United States
Novartis Pharmaceuticals

Terminated

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, Denmark, Italy, Netherlands, Spain, Sweden, United Kingdom, France
Stanford University
National Institute of Mental Health (NIMH); Autism Speaks

Completed

Randomized Controlled Study of Donepezil in Fragile X Syndrome

Fragile X Syndrome

United States
Novartis Pharmaceuticals

Terminated

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes (EXPLAIN)

Fragile-X Syndrome

Germany
FRAXA Research Foundation
Fragile X Research Foundation of Canada

Completed

Add-on Pilot Trial of Minocycline to Treat Fragile X Syndrome

Fragile X Syndrome

Canada
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome

Fragile X Syndrome

United States, Belgium, Australia, Israel, Switzerland, Germany, France, Canada, Denmark, Indonesia, Italy, Netherlands, Spain, Sweden, Turkey, United Kingdom
Seaside Therapeutics, Inc.

Completed

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

Fragile X Syndrome

United States
Seaside Therapeutics, Inc.

Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome (Harbor-A)

Fragile X Syndrome

United States
Seaside Therapeutics, Inc.

Terminated

An Open Label Extension Study in Subjects With Fragile X Syndrome (209FX303)

Fragile X Syndrome

United States
Seaside Therapeutics, Inc.

Suspended

A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Neuropharm

Completed

Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome

Fragile X Syndrome

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Nanfang Hospital, Southern Medical University

Recruiting

A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL (ABC)

Acute Lymphoblastic Leukemia | Philadelphia Chromosome | Adult ALL | Philadelphia-Positive ALL | IKZF1 Gene Mutation

China
Novartis Pharmaceuticals

Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Myeloid Leukemia, Philadelphia Positive

Korea, Republic of, Germany, France, United States, Greece, Hungary, Italy, Japan, Poland, Russian Federation, Thailand, Turkey, China, Netherlands
Novartis Pharmaceuticals

Terminated

Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib (MACS0254)

Chronic Myelogenous Leukemia - Chronic Phase

United States
University of Hawaii
National Institute of General Medical Sciences (NIGMS)

Recruiting

Keiki (Pediatric) Produce Prescription (KPRx) Program Hawaii (KPRxHawaii)

Obesity | Food Selection | Malnutrition, Child | Nutrition Poor

United States
University of Copenhagen
Swansea University

Active, not recruiting

Exercise Training and Thrombotic Risk in Post-menopausal Women (TIME)

Thrombosis | Menopause | Exercise Training | Vascular Dilation

Denmark
National Taiwan University Hospital

Unknown

Culture System for Isolating Circulating Tumor Cells

Early Detection of Cancer

Taiwan
University Hospital, Antwerp

Completed

Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults

Nociceptive Pain | Monitoring, Intraoperative

Belgium
Changhai Hospital
Tongji Hospital; Qilu Hospital of Shandong University; First Affiliated Hospital... and other collaborators

Completed

Premedication Simethione Improves Visibility During Bowel Cleansing for Colonoscopy

Adenoma Detection Rate | Bowel Preparation Scale | the Amount of Air Bubble

China
DermTech

Completed

DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years (TRUST)

Melanoma Detection

United States

Clinical Trials on Chromosome 5q Deletion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations